![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 13, 2019 1:09:46 PM
GHP Q and A
By using our site you accept the terms of our cookie policy
?
Global Health & Pharma Logo
Search
Research & Development
Translation & Commercialisation
Funding & Investment
Education &
Skills
Innovation & Technology
Health &
Social Care
Regulation &
Policy
About Us
Circulation
Awards
Issues
Contact Us
Subscribe
GHP Award FAQ
October 15, 2018
How long has Global Health & Pharma been in circulation for?
Global Health & Pharma has been running for over three years and is a global information sharing platform. Established to enhance communication networks & collaboration across all themes and disciplines within 3 main categories; Human, Animal & Environmental Health. Global Health and Pharma is unusual as it operates a novel & proprietary member community model, rather than the traditional visitor and reader model. This is effective as it helps the publication determine which themes are currently the most pertinent to discuss within the market. This model has helped us attract a strong readership of 260,000 people worldwide and is ever increasing. Global Health & Pharma is one of the many publications by AI Global Media, a UK based publisher which has published over 200 worldwide publications to its name since 2010.
Where did the nomination come from?
In the interest of maintaining high response rates, we do not ask nominees to reveal their personal identity. As mentioned in the methodology, we frequently nominate candidates ourselves. When it comes to the process of voting, if you didn’t cast a vote by self-submission it is likely to have been cast via a colleague or client who has received one of our direct invitations. The main ethos of our awards system is that your ability to succeed is not linked to the number of votes received, with the key belief behind this being that all awards will be received purely on merit. As a means of identifying spam votes and countering cyber-threats, we are constantly monitoring the site for unusual behaviour.
What happens if I agree to be on the shortlist?
As we look to keep maximum focus on relevant candidates, we ask all nominees to accept their position on the shortlist. This also gives people complete control in their decision on whether they would like to move forward with the award. There is no cost for you to be added onto the shortlist or for any of our winners. Nominees who accept will then proceed to our rigorous internal vetting procedure. They are given an opportunity to present their own data which gets considered alongside the information collated by our research team. It can take up to 8 weeks for research to be completed.
Who makes the final decision?
We employ an entirely impartial panel of 5 individuals to conduct all of the research to our high standards. At the helm of the panel we have a veteran academic leader with international academic and training experience. They are well versed in research, fact-checking and mediation. We believe this method is the most efficient in determining which individuals and companies are most deserving in winning an award and has brought us much success and commendation throughout its use. Our continued use of this panel plays a key part in enforcing Global Health & Pharma’s stance that winners are not determined by popularity of votes, but by their contributions to the sector.
Is there a winner’s ceremony/award dinner and if so, when does it take place?
We do not focus our efforts on a celebratory event. Despite being an enjoyable occasion, it doesn’t support our group’s philosophy of cost-effective marketing. As well as the lack of cost efficiency, Global Health & Pharma is an establishment which runs awards worldwide and we believe it would be logistically difficult for some of our winners to attend an awards ceremony. We follow the belief that any of the optional costs involved with the award would be more beneficial in a year’s worth of online marketing for a winner, rather than spending it all on a ceremonial evening. All of our press announcements are made digitally, online and across our network to enforce our position as digital publishers. We aim to arm you with the tools (both digital and physical) to generate real-world value.
What happens if I am deemed successful?
There is a short press embargo in place where we ask you not to make the news public, giving us the chance to prepare the different means of coverage we offer for companies. This means that during this period the program manager will liaise with you to agree on the most appropriate coverage for you. Our main feature takes the form of a digital celebratory magazine, but we also offer physical trophies, wall mounted and digital certificates, web-based advertisements and generic press releases which are bespoke to you or your company. This variety of options are aimed to make the awards tailor made to each individual firm, not matter which one you decide to go for.
Are there any costs involved?
As previously mentioned there are no compulsory costs in accepting a nomination or winning an award with Global Health & Pharma. We do offer a variety of paid additional benefits for our winners, but these are completely optional and merely supplementary to your award rather than essential. To demonstrate our commitment to no mandatory fees, all our winners are offered a free of charge promotional package. Our company policy will always remain: regardless of budget, our clients should always be able to garner the full value of the award and our seal of approval. We offer a variety of promotional opportunities to our winners. as we have an extensive network and we know, more than anyone, the wider business benefits from promoting industry awards.
Q3 2019
Q3 2019
View Issue
Testimonials
That standard of excellence comes from the top - and that's you!
Mike Heintz, Clinical Care Manager
Award Spotlight
Biotechnology Awards 2020
Vote Now
Social Care Awards 2020
Vote Now
Contact Us
+44 (0) 203 725 6847
Global Health & Pharma
Floor 2, Suite F
The Maltsters
1-2 Wetmore Road
Burton On Trent
Staffordshire
DE14 1LS
T: +44 (0) 203 725 6847
Site Links
Research & Development
Translation & Commercialisation
Funding & Investment
Education &
Skills
Innovation & Technology
Health &
Social Care
Regulation &
Policy
About Us
Circulation
Awards
Issues
Contact Us
Subscribe
Terms & Conditions
Website Terms of Sale
Privacy Policy
Cookie Policy
VAT: 100361775
Recent OZSC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 07:52:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 07:54:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/31/2024 04:15:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 09:10:52 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/22/2024 08:31:28 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 06/18/2024 09:23:10 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 06/06/2024 09:08:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:03:12 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/23/2024 09:59:05 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/12/2024 09:56:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 08:15:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:00:50 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 03:33:21 PM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM